Full-Time

Supply Chain Transformation Director

For Medical Devices

Philips

Philips

Healthcare technology for diagnosis, care, wellness

Compensation Overview

$144.8k - $193k/yr

+ Annual Incentive Bonus + Sales Commission + Long-Term Incentives

Wayzata, MN, USA + 1 more

More locations: Colorado Springs, CO, USA

In Person

Office-based role; at least 3 days on-site per week.

Category
Operations & Logistics (1)
Required Skills
Supply Chain Management
Requirements
  • Bachelor's degree in Mechanical, Electro-mechanical, Industrial Engineering or equivalent; Master's Degree is preferred.
  • Eighteen years of experience in Operations and Supply chain domains, or a Master's degree with fifteen years of experience in Operations and Supply chain domains.
  • This is a people leader role of a team of eight direct reports; must be able to successfully perform the duties of leading such a team.
  • Skills include Supply Chain Management, Program Management and Change Management, People Management, and Executive Stakeholder Management.
  • Must be able to successfully perform the minimum Physical, Cognitive and Environmental job requirements with or without accommodation.
Responsibilities
  • Develop and implement a strategic roadmap aligned with best practices and the overall business objectives, including a customer-centric mindset, setting clear goals and objectives, defining key performance indicators, and creating a roadmap for achieving transformational outcomes.
  • Develop, implement, and execute programs aligned with the organization's strategic objectives, including governance models, defining program scope, goals, deliverables, and timelines; coordinate cross-functional teams and stakeholders to ensure smooth program execution.
  • Provide leadership and guidance to teams from different functions involved in program execution; foster a collaborative and high-performing team environment; coach and mentor team members, provide feedback, and support their professional development.
  • Identify and deliver opportunities to streamline and optimize supply chain processes, including sterilization strategy implementation, make vs buy program development, network design optimization, end-to-end technology and AI platforms for supply chain/manufacturing, Operational Excellence, and Cost to Deliver optimization.
  • Build and develop a high-performing supply chain transformation team capable of driving and sustaining new capabilities and solutions.
  • Drive innovation initiatives to leverage emerging technologies and trends in supply chain management, such as automation and AI, to enhance operational efficiency and agility.
  • Foster a culture of continuous improvement within the supply chain by encouraging innovation, fostering experimentation, and promoting a mindset of agility and adaptability; implement best practices and standards to ensure compliance with regulatory requirements and industry standards while maintaining high levels of operational excellence.
  • Stay abreast of industry trends, market dynamics, and technological advancements to anticipate future challenges and opportunities, driving proactive adjustments to the supply chain strategy.
Desired Qualifications
  • Master's Degree is preferred.

Philips develops health technology across professional medical devices, connected care, and consumer health products. Its offerings include diagnostic imaging and image-guided therapy, patient monitoring and clinical informatics, and everyday wellness products like oral and personal care. The company increasingly delivers integrated solutions through a Healthcare-as-a-Service subscription model and long-term partnerships with hospitals and health systems. Its aim is to improve people’s health and well-being by making advanced health technology easier to access and integrate into care.

Company Size

N/A

Company Stage

IPO

Headquarters

Andover, Minnesota

Founded

1891

Simplify Jobs

Simplify's Take

What believers are saying

  • Aims to improve 2.5 billion lives yearly by 2030 via partnerships.
  • Partnered with HealthAlliance Hospital for advanced imaging and monitoring.
  • Strong global presence in North America, Europe, and emerging markets.

What critics are saying

  • 2021 Respironics recall triggers ongoing lawsuits and erodes Connected Care trust.
  • GE HealthCare's AI MRI scanners outperform Philips in speed and quality.
  • $1.1 billion DreamStation settlement drains cash and deters HaaS deals.

What makes Philips unique

  • Philips segments into Diagnosis & Treatment, Connected Care, and Personal Health.
  • Shifting to Healthcare-as-a-Service model with subscription-based solutions.
  • Launched Shavetopia metaverse in Roblox for Movember men's health awareness.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Health Savings Account/Flexible Spending Account

Company News

HIT Consultant
Apr 12th, 2024
Philips Respironics Reaches Final Agreement With Us Regulators On Sleep Apnea Device Recall

<img src="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp" alt="Philips Respironics Reaches Final Agreement with US Regulators on Sleep Apnea Device Recall. " class="wp-image-78777" srcset="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp 700w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-300x161.webp 300w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-290x155.webp 290w" sizes="(max-width: 700px) 100vw, 700px">What You Should Know: – Philips Respironics, a subsidiary of Royal Philips, has finalized a consent decree with the US Department of Justice (DOJ) and Food and Drug Administration (FDA) to address issues raised during a 2021 inspection of a Philips facility in Pennsylvania.– The agreement focuses on Philips Respironics’ operations in the US, particularly regarding the recall of certain sleep and respiratory care devices.– The company’s focus will now be on completing remediation efforts, ensuring patient safety, and regaining regulatory approval to resume sales of new devices in the US.Focus on Remediation and ComplianceThe consent decree outlines a roadmap for Philips Respironics to:Prioritize Recall Remediation: Philips will continue efforts to remediate millions of sleep apnea and respiratory care devices recalled in June 2021 due to potential health risks associated with degraded sound abatement foam.Independent Oversight: Independent experts will be brought in to review recall remediation efforts and ensure Philips Respironics’ business operations comply with FDA regulations.Continued Patient Support: Philips Respironics can continue servicing existing devices in the hands of patients and healthcare providers. Additionally, they can sell accessories, consumables, and replacement parts for these devices.Sales Restrictions Remain in USThe FDA has not yet authorized Philips Respironics to resume sales of new CPAP, BiPAP, or other respiratory care devices in the US. This restriction will remain in place until Philips meets the requirements outlined in the consent decree.Global Sales Continue with RestrictionsPhilips Respironics can continue to sell new devices, accessories, consumables, and replacement parts outside the US,  subject to specific requirements.Safety of Devices with New Foam ConfirmedPhilips Respironics has conducted tests on devices using a new silicone sound abatement foam and found no safety issues. Patients can continue to use these devices following the instructions for use.Financial ImpactPhilips anticipates incurring costs associated with remediation activities and profit disgorgement related to US sales. These costs are estimated at 100 basis points in 2024.  The company’s previously announced 2023-2025 financial outlook remains unchanged,  already factoring in the consent decree. “Strengthening patient safety and quality remains Philips’ highest priority and the increased scrutiny will help us to improve even more

Goodrich Pharmacy
Jan 29th, 2024
Phillips Suspends U.S. Sales of CPAP, Ventilator Machines After Recall

Following a recall of millions of its breathing machines that began in mid-2021, Phillips Respironics announced Monday that it would halt sales of all such machines within the United States.

Parker Waichman LLP
Mar 23rd, 2023
Sleep Apnea Patients Suffer While Waiting To Receive Their Repaired Philips CPAP Machines

In June of 2021, Philips began a recall of over five million of its breathing devices due to toxic fume and substances emanating from the devices’ sound abatement foam.

Digital Journal
Jan 13th, 2023
Ultrasound Market Share | Market | Report | Analysis 2032 | Key Players: Fujifilm Holdings Corporation, Analogic Corporation, Siemens Healthcare among others

February 2019 – Koninklijke Philips launched the EPIQ Elite ultrasound system in the market.

VentureBeat
Oct 26th, 2022
Philips Norelco Brings Movember To Roblox With Shavetopia

Register now for your free virtual pass to the Low-Code/No-Code Summit this November 9. Hear from executives from Service Now, Credit Karma, Stitch Fix, Appian, and more. Learn more. Philips Norelco is creating an interactive metaverse experience called Shavetopia in Roblox, based around the Movember trend. For anyone who doesn’t know what that is, Movember is where people grow facial hair for the entire month of November. The portmanteau comes from adding the word mustache to the name of the month